猫的新陈代谢异常和重编程自然发生的高性心肌病变
Qinghong Li1, Max Homilius2, Erin Achilles3
1Nestlé Purina Research, St. Louis, Missouri, USA.
ESC heart failure
|November 5, 2024
概括
猫类高性心肌病变 (HCM) 改变了能量代谢,脂质样本和谷氨平衡. 这项研究揭示了HCM猫的关键代谢变化,为疾病机制提供了洞察力.
科学领域:
- 心脏病学 心脏病学
- 代谢学 代谢学 代谢学
- 兽医医学 兽医医学 兽医医学
背景情况:
- 心脏是代谢器官,心脏衰竭会重新编程能量基板的利用,增加氧气消耗和氧化应激.
- 猫的多变性心肌病 (HCM) 与人类的HCM有相似之处,但疾病机制尚未完全理解.
- 在猫类HCM中表征代谢变化可以提供有关疾病进展的见解.
研究的目的:
- 描述健康猫的全球代谢变化,与患有不同阶段的多变性心肌病 (HCM) 的猫相比.
- 为了确定特定的代谢物和代谢途径在猫类HCM中发生变化.
- 了解代谢障碍与猫类HCM疾病严重程度之间的关系.
主要方法:
- 来自83只猫的血清样本的非向代谢分析 (23个对照组,31个B1阶段,12个B2阶段,17个C阶段HCM).
- 调整为年龄,性别和体重的多重线性回归被用于统计比较.
- 分析发现,在各组中,有167种显著不同的代谢物.
主要成果:
- 脂质代谢的显著变化,包括甘油脂,脂和胆固醇.
- 在HCM猫的血清中增加了自由脂肪酸,3-基脂肪酸,甲酸和克雷布斯循环中间体 (糖酸盐,酸盐,α-甲酸盐) 的度.
- 改变了谷氨代谢,导致囊和囊-谷氨二硫化物水平升高,眼病增加,NAD+前体 (尼古丁胺胺,三) 减少.
- 在HCM猫中,尿素毒素 (guanidino化合物,与蛋白质结合的布特雷辛) 的积累.
结论:
- 猫类HCM与能量代谢失调,脂质样式变化和谷氨稳定性受损有关.
- 代谢变化表明猫 HCM 中心石结构/功能和脂质信号受到干扰.
- 尿素毒素的升高表明猫类HCM晚期可能存在功能障碍.
更多相关视频
05:04In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter
Published on: February 22, 2022
3.4K
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
3.0K
相关概念视频
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
